MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$496,304K
Short-term investments
$331,487K
Accounts receivable, net
$127,425K
Inventory
$40,475K
Prepaid expenses and
other current assets
$14,905K
Prepaid taxes
$14,006K
Total current assets
$1,024,602K
Property and equipment,
net
$150,776K
Long-term investments
$128,066K
Deferred tax asset, net of
valuation allowance
$22,824K
Right-of-use assets
$7,239K
Other non-current
assets
$287K
Total assets
$1,333,794K
Total liabilities and
stockholders equity
$1,333,794K
Total stockholders
equity
$1,219,560K
Total liabilities
$114,234K
Additional paid-in capital
$1,194,261K
Retained earnings
(accumulated deficit)
$24,163K
Accumulated other
comprehensive income (loss)
$1,136K
Total current
liabilities
$102,942K
Lease liability
$7,568K
Other long-term
liabilities
$3,724K
Accrued rebates
$58,181K
Accrued expenses and
other current...
$39,752K
Accounts payable
$3,238K
Current portion of lease
liability
$1,771K
Back
Back
Balance Sheet
source: myfinsight.com
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)